Clinical Trials in Miami

Showing 361-380 of 5,521 trials

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

NCT05233397

ACTEMRA (tocilizumab) is an IL-6 receptor antagonist used for the treatment of adult Rheumatoid Arthritis as well as Polyarticular (PJIA) and Systemic (SJIA) Juvenile Idiopathic Arthritis. In this Phase II, the drug will be used to treat pediatric patients diagnosed with recurrent Adamantinomatous Craniopharyngioma including patients who have undergone surgery and/or radiation therapy.

Adamantinomatous CraniopharyngiomaRecurrent Adamantinomatous Craniopharyngioma

Nationwide Children's Hospital38 participantsStarted Dec 2022

Aurora, Colorado, United States • Washington D.C., District of Columbia, United States • Miami, Florida, United States +9 more locations

NOT_YET_RECRUITINGNA< 1 mile

Food Intake and Thermogenesis in High Spinal Cord Injury

NCT07103993

The purpose of this research is to determine the effects of food on cardiovascular and metabolic health in men with and without spinal cord injury (SCI).

SCI - Spinal Cord Injury

University of Miami56 participantsStarted May 2026

Miami, Florida, United States

ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma

Food Intake and Thermogenesis in High Spinal Cord Injury

Find Trials by Condition in Miami

Exploring the Effect of Mindfulness on Quality of Life (QoL) in Spinal Cord Injury (SCI)

Total Knee Arthroplasty Infiltration Study for Postoperative Analgesia

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

ADVENT Post Approval Study

Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

Mobile Health for Adherence in Breast Cancer Patients

Comparing Two Methods to Follow Patients With Pancreatic Cysts

A Study of ASP3082 in Adults With Advanced Solid Tumors

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

GENERATION HD2. A Study to Evaluate the Safety, Biomarkers, and Efficacy of Tominersen Compared With Placebo in Participants With Prodromal and Early Manifest Huntington's Disease

A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

Proof-of-concept Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of SION-719 When Added to Trikafta

A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

Long Term Safety & Efficacy Study Evaluating The Effect of A4250 in Children With PFIC

Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of GM1 Gangliosidosis or GM2 Gangliosidosis

A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)